During the past decade, Integrative Clinical Trials, LLC conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 12 clinical trials were completed, i.e. on average, 38.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 11 clinical trials were completed. i.e. 68.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Integrative Clinical Trials, LLC" #1 sponsor was "Biohaven Pharmaceuticals, Inc." with 3 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored, "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "AstraZeneca" with 2 trials sponsored and "H. Lundbeck A/S" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Integrative Clinical Trials, LLC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Neumora Therapeutics, Inc." with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Integrative Clinical Trials, LLC" are "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (5 trials), "Migraine" (3 trials), "Mild Cognitive Impairment" (3 trials) and "Adjunctive Treatment of Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Integrative Clinical Trials, LLC" in a lesser frequency.

Most popular intervention types in "Integrative Clinical Trials, LLC" are "Drug" (30 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Eptinezumab" (2 trials), "Lanabecestat" (2 trials), "Pimavanserin" (2 trials) and "AC-1204" (1 trials). Other intervention names were less common.

The vast majority of trials in "Integrative Clinical Trials, LLC" are 32 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Integrative Clinical Trials, LLC". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in Integrative Clinical Trials, LLC, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Integrative Clinical Trials, LLC, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".